A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease

NCT06810960 · clinicaltrials.gov ↗

RECRUITING

Status

3000

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

OTHER: No Intervention

Sponsor

Eisai Korea Inc.